Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.180
-0.030 (-2.48%)
Apr 25, 2025, 12:35 PM EDT - Market open
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $56.94 million as of April 25, 2025. Its market cap has decreased by -11.28% in one year.
Market Cap
56.94M
Enterprise Value
-58.47M
1-Year Change
-11.28%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $56.94M, a decrease of -89.71%. That is a compound annual growth rate of -42.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 58.39M | -26.22% |
| Dec 31, 2024 | 79.14M | -16.75% |
| Dec 29, 2023 | 95.07M | -1.43% |
| Dec 30, 2022 | 96.44M | -78.58% |
| Dec 31, 2021 | 450.27M | -18.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.11B |
| UnitedHealth Group | 388.06B |
| Johnson & Johnson | 372.59B |
| AbbVie | 317.39B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.54B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |